MedTrace Logo

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

NCT01010282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2015-08-17

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.

Conditions

  • Dry Eye Syndrome

Interventions

DRUG

Glycerin and Polysorbate 80 based artificial tear

1-2 drops in each eye, as needed, but at least twice daily

DRUG

Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear

1-2 drops in each eye, as needed, but at least twice daily

DRUG

Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear

1-2 drops in each eye, as needed, but at least twice daily

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01010282 on ClinicalTrials.gov